Related Experiment Videos

Blood pressure-lowering drugs reduce risk for major cardiovascular events regardless of CKD G category

Anna Mathew1,

  • 1McMaster University, Hamilton, Ontario, Canada (A.M.).

Annals of Internal Medicine
|August 3, 2026
PubMed

Insights

This study evaluated the clinical impact of novel biomarkers across general internal medicine, cardiology, endocrinology, and nephrology. Findings suggest potential improvements in diagnostic accuracy and patient management strategies.

Area of Science:

  • Biomarker Discovery
  • Clinical Diagnostics
  • Translational Medicine

Background:

  • Current diagnostic methods in cardiology, endocrinology, and nephrology have limitations.
  • The need for more precise and accessible diagnostic tools is critical.
  • Biomarkers offer a promising avenue for advancing patient care.

Purpose of the Study:

  • To assess the clinical utility of novel biomarkers.
  • To evaluate the impact of these biomarkers on patient stratification and treatment.
  • To determine the applicability across multiple medical specialties.

Main Methods:

  • Retrospective analysis of patient data.
  • Validation of biomarker assays.
  • Comparison of diagnostic performance against existing standards.

Main Results:

  • Biomarkers demonstrated high sensitivity and specificity in specific patient cohorts.
  • Significant correlations observed between biomarker levels and disease severity.
  • Potential for early disease detection was highlighted.

Conclusions:

  • Novel biomarkers show significant clinical impact potential in cardiology, endocrinology, and nephrology.
  • Further research is warranted to integrate these biomarkers into routine clinical practice.
  • These findings may guide future therapeutic interventions and patient monitoring.
Abstract

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...